Literature DB >> 31802349

Prevalence of musculoskeletal complaints in urban communities in multi-ethnic Suriname: a cross-sectional study with the COPCORD methodology (stage 1, phase 1 and 2).

N Ho-A-Tham1,2, Y Vanlandewijck3, L de Donder4, R Wittoek5, B Ting-A-Kee6, R Basantram7, W Dankaerts8.   

Abstract

INTRODUCTION/
OBJECTIVES: Musculoskeletal complaints (MSCs) are a major burden worldwide. In Suriname, a South American developing country, the epidemiology of MSCs and its related disorders is still unknown. Therefore, a cross-sectional survey was carried out to determine prevalence and risk factors of MSCs in urban areas of Suriname.
METHODS: This is the first Community Oriented Program for the Control of Rheumatic Diseases survey in a Caribbean Community. Trained interviewers collecting self-reported data conducted this house-to-house community-based survey. Data was analyzed using SPSS version 23 and Stata version 14.1.
RESULTS: The prevalence of MSCs was 62.1% with a higher prevalence rate among women compared with men (resp. 64.3% vs. 58.6%) (Odds ratio = 1.185; p ≤ 0.05). The most decisive self-reported variables associated with MSCs were older age (defined as ≥ 45 years) and moderate to heavy physical workload. The prevalence of MSCs was also associated with women, low educational level, smoking, alcohol use, high-intensity physical activity level, and body mass index (≥ 25 kg/m2). The highest prevalence of MSCs was found among African descendants (Maroons (68.8%) and Creoles (68.0%)), followed by the Indigenous (65.0%) and Asian descendants (Hindustani (64.3%) and Javanese (49.5%)). Most persons with MSCs (75.7%) reported multisite complaints with lower back, knee, and shoulder being the most frequently reported sites. In our study population, MSCs were not considered disabling (mean Health Assessment Questionnaire Disability Index score of 0.23).
CONCLUSIONS: The prevalence of MSCs in this urban multi-ethnic Surinamese community is high; therefore, future research is needed to further explore the burden of MSCs in Suriname.Key Points• Musculoskeletal complaints are highly prevalent in different ethnic groups in an urban Surinamese community; almost two-thirds of the population reported MSCs with the highest prevalence rate among women and African descendants.• The most decisive self-reported variables associated with MSCs were older age (defined as ≥ 45 years) and moderate to heavy physical workload. Gender, educational level, smoking, alcohol use, high-intensity physical activity, and body mass index were also significantly associated with musculoskeletal complaints.

Entities:  

Keywords:  COPCORD; Ethnicity; Musculoskeletal complaints; Prevalence; Suriname

Mesh:

Year:  2019        PMID: 31802349     DOI: 10.1007/s10067-019-04842-5

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  34 in total

1.  Multimorbidity: prevalence, effect on quality of life and daily functioning, and variation of this effect when one condition is a rheumatic disease.

Authors:  Estíbaliz Loza; Juan A Jover; Luis Rodriguez; Loreto Carmona
Journal:  Semin Arthritis Rheum       Date:  2008-03-12       Impact factor: 5.532

2.  The Economic Burden of Musculoskeletal Disease in Children and Adolescents in the United States.

Authors:  Scott B Rosenfeld; Katherine Schroeder; Sylvia I Watkins-Castillo
Journal:  J Pediatr Orthop       Date:  2018-04       Impact factor: 2.324

Review 3.  Risk factors for work-related musculoskeletal disorders: A systematic review of recent longitudinal studies.

Authors:  Bruno R da Costa; Edgar Ramos Vieira
Journal:  Am J Ind Med       Date:  2010-03       Impact factor: 2.214

Review 4.  Epidemiology of rheumatic musculoskeletal disorders in the developing world.

Authors:  Arvind Chopra; Ahmed Abdel-Nasser
Journal:  Best Pract Res Clin Rheumatol       Date:  2008-08       Impact factor: 4.098

5.  Smoking, low formal level of education, alcohol consumption, and the risk of rheumatoid arthritis.

Authors:  U Bergström; L T H Jacobsson; J Å Nilsson; E Wirfält; C Turesson
Journal:  Scand J Rheumatol       Date:  2012-11-06       Impact factor: 3.641

Review 6.  Burden of major musculoskeletal conditions.

Authors:  Anthony D Woolf; Bruce Pfleger
Journal:  Bull World Health Organ       Date:  2003-11-14       Impact factor: 9.408

Review 7.  The global burden of other musculoskeletal disorders: estimates from the Global Burden of Disease 2010 study.

Authors:  Emma Smith; Damian G Hoy; Marita Cross; Theo Vos; Mohsen Naghavi; Rachelle Buchbinder; Anthony D Woolf; Lyn March
Journal:  Ann Rheum Dis       Date:  2014-03-03       Impact factor: 19.103

8.  A National Surveillance Survey on Noncommunicable Disease Risk Factors: Suriname Health Study Protocol.

Authors:  Ingrid Sk Krishnadath; Christel Cf Smits; Vincent Wv Jaddoe; Albert Hofman; Jerry R Toelsie
Journal:  JMIR Res Protoc       Date:  2015-06-17

Review 9.  Recommendations from the Community Oriented Program for Control of Rheumatic Disease for data collection for the measurement and monitoring of health in developing countries.

Authors:  John Darmawan
Journal:  Clin Rheumatol       Date:  2007-03-16       Impact factor: 3.650

10.  Physical inactivity is associated with chronic musculoskeletal complaints 11 years later: results from the Nord-Trøndelag Health Study.

Authors:  Helene Sulutvedt Holth; Hanne Kine Buchardt Werpen; John-Anker Zwart; Knut Hagen
Journal:  BMC Musculoskelet Disord       Date:  2008-12-01       Impact factor: 2.362

View more
  2 in total

1.  Epidemiology of musculoskeletal complaints and diseases in Qatar: A cross-sectional study.

Authors:  Housam Aldeen Sarakbi; Omar Alsaed; Mohamed Hammoudeh; Abdo Lutf; Abdul Razzakh Poil; Ayah Ziyada; Samar Al-Emadi
Journal:  Qatar Med J       Date:  2020-11-12

2.  Low back pain prevalence, beliefs and treatment-seeking behaviour in multi-ethnic Suriname.

Authors:  Nancy Ho-A-Tham; Beverly Ting-A-Kee; Niels Struyf; Yves Vanlandewijck; Wim Dankaerts
Journal:  Rheumatol Adv Pract       Date:  2021-11-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.